Cargando…
Current Management and Future Perspective in Pleural Mesothelioma
SIMPLE SUMMARY: Platin-based chemotherapy with pemetrexed has been the backbone of meaningful treatment in pleural mesothelioma for the last 16 years, alongside vinorelbine and gemcitabine, which show only modest response. Recently, a nivolumab and ipilimumab combination was approved, and it offers...
Autores principales: | Shah, Rajiv, Klotz, Laura V., Glade, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869935/ https://www.ncbi.nlm.nih.gov/pubmed/35205798 http://dx.doi.org/10.3390/cancers14041044 |
Ejemplares similares
-
Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
por: Hotta, Katsuyuki, et al.
Publicado: (2020) -
Clinical staging of malignant pleural mesothelioma: current perspectives
por: Bonomi, Maria, et al.
Publicado: (2017) -
Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016) -
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
por: Nicolini, Fabio, et al.
Publicado: (2020) -
Current status and progress in immunotherapy for malignant pleural mesothelioma
por: Sun, Boyang, et al.
Publicado: (2022)